CRISPR Therapeutics AG logo
CRISPR Therapeutics AG CRSP
$ 40.62 0.57%

Quarterly report 2024-Q3
added 11-05-2024

report update icon

CRISPR Therapeutics AG Operating Income 2011-2024 | CRSP

Annual Operating Income CRISPR Therapeutics AG

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-223 M -673 M 374 M -354 M 46.7 M -159 M -64.6 M -68.1 M -25.7 M -6.63 M - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
374 M -673 M -115 M

Quarterly Operating Income CRISPR Therapeutics AG

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-110 M -151 M -141 M - -132 M -95.2 M -64.5 M - -182 M -183 M -176 M - -129 M 763 M -115 M -108 M -92.4 M -80.7 M -73.6 M 11 M 139 M -55 M -48.4 M -45.2 M -49.4 M -37.3 M -27 M 972 K -23.6 M -21.3 M -20.7 M -25.3 M -14.6 M -16.6 M -11.7 M -12.2 M -6.2 M -3.62 M -3.74 M - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
763 M -183 M -37.3 M